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Abstract 
In KB cells, interleukin-1 (IL-l), epidermal growth factor and phorbol ester transiently activated both MAP kinase and a serine kinase which 
phosphorylated the heat shock protein hsp27. Extracts made from IL-l-stimulated KB cells phosphorylated recombinant hsp27, in vitro, on serine 
residues 78 and 82 which are contained within Arg-X-X-Ser motifs similar to those phosphorylated by the ribosomal protein S6 kinases. Upon size 
exclusion chromatography, however, hsp27 kinase eluted as a single peak of activity at 50-60 kDa, clearly separated from ribosomal protein S6 
kinases. Treatment of partially purified hsp27 kinase with protein phosphatase-2a reduced its activity by 80%. De-phosphorylated hsp27 kinase could 
be approximately 50% reactivated by a factor present in IL-l-treated cell extracts in the presence of ATP. This factor co-eluted with MAP kinase 
after partial purification by DEAE-cellulose, phenyl Sepharose, and size exclusion chromatography. Purified sea star p44mpk and recombinant ERK2 
MAP kinases were also capable of re-activating hsp27 kinase to a similar extent. These data suggest hat hsp27 kinase is downstream from, and 
probably a direct target of MAP kinase. 
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1. Introduction 
Interleukin-1 (IL-l) is a cytokine capable of inducing 
many pro-inflammatory and immunologic responses [ 11. 
The signal transduction pathways linking cell surface 
IL-l receptors to gene activation are unclear [2], but one 
of the earliest cellular responses to IL-l is the activation 
of protein serine/threonine kinases. We recently identi- 
fied [3] one class of these enzymes as mitogen-activated 
protein kinases (MAP kinases, also called extracellular- 
signal regulated kinases, reviewed in [4]). MAP kinases 
are activated by many different extracellular stimuli 
which may associate with cellular receptors having inte- 
gral or associated tyrosine kinases, or which couple with 
GTP-binding proteins [5]. As well as stimulating the ac- 
tivity of MAP kinase, IL-1 has been shown to cause the 
rapid phosphorylation of the small heat shock protein 
hsp27 in fibroblasts, endothelial cells, HepG2 hepatoma 
cells and U937 cells [6-Q. The synthesis of hsp27 is ele- 
vated in response to various cellular insults and it may 
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play a role in the development of tolerance to heat shock 
[9] or other stresses. Although the precise cellular func- 
tion of this protein is not known, it inhibits the polymer- 
ization of actin [lo]. As is the case for MAP kinase 
activation, many other agents besides IL-l have been 
reported to cause increased hsp27 phosphorylation in 
various cells. These include tumor necrosis factor [6], 
bradykinin [8], fibroblast growth factor, ATP [8], serum, 
PMA [l 11, and leukemia inhibitory factor [12]. Recently, 
the major sites of phosphorylation of human hsp27 [13] 
and its murine homolog [14] were found to reside in the 
conserved motif Arg-X-X-Ser, a motif that is also recog- 
nized by ribosomal protein S6 kinase II (RSK). RSK is 
phosphorylated and activated by MAP kinase [15]. The 
aim of the present study was to determine if the IL-l- 
stimulated hsp27 kinase activity is, like RSK, potentially 
dependent upon upstream activation of MAP kinase. 
2. Materials and methods 
2. I. Materials 
KB (ATCC CCL1 7) human epidermoid carcinoma cells were main- 
tained in Dulbecco’s modified medium (DMEM) supplemented with 
10% fetal bovine serum (Intergen, Purchase NY) and were used within 
24 h of attaining confluence. Cells were stimulated with IL-l& (20 
@ml), PMA (100 r&ml, added in DMSO, 0.01% final DMSO concen- 
tration) of EGF (50 &ml) by the direct addition of these agents to the 
maintainance medium, typically for 15 min, before cell lysis as de- 
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scribed below. Human recombinant IL-l was prepared as described 
previously [3], EGF was obtained from Sigma. Recombinant human 
hsp27, expressed in E. coli. and a monoclonal antibody reactive against 
hsp27 were purchased from StressGen Biotechnologies Corp., (Victoria 
B.C., Canada). MAP kinase substrate peptide T669 (RRREL- 
VEPLTPSGE) and peptide S82 (RRRALSRQLSSGVSEIA) corre- 
sponding, respectively, to amino acid residues 663-673 of the human 
EGF receptor [16] plus three additional N-terminal arginine residues 
and to amino acids 75-88 of hsp27 [17] includmg two additional N- 
terminal arginines were synthesized on an Applied Biosystems 430A 
peptide synthesizer and were purified by hplc. Identity and purity of 
each peptide was confirmed by zszCf mass spectrometry. The peptide 
RRRLSSLRA correspondmg to amino acids 231-239 of human 40s 
ribosomal protein S6 [18] was purchased from UBI. (Lake Placid, NY). 
The pseudosubstrate inhibitor of protein kinase C (RFARKGALRQ- 
KNV) and protein kinase A inhibitor (TTYADFIASGRTGRRNAI- 
HD) were synthesized as described above. Protein phosphatase_2a, and 
MAP kinase ~44 mpk from Plsaster ochraceus were purchased from UBI. 
Recombinant rat ERK-2 containing a 6 histidine N-terminal extension 
was expressed in E. coli and activated with highly purified rabbit skel- 
etal muscle MAP kinase kinase and was the kind gift of Dr. Lee Graves 
(University of Washington, Seattle, WA). Okadaic acid was obtained 
from Gibco BRL (Grand Island, NY) 
2.2 Protem kinase assays 
KB cell monolayers were treated with IL-l or other agents for vari- 
ous times, washed with ice-cold PBS containing 0.2 mM sodium ortho- 
vanadate and then scraped into a lysis buffer (1 ml per lo7 cells) contain- 
ing 30 mM MOPS, pH 7.0110% (w/v) glycerol/80 mM /J-glycero- 
phosphate/20 mM EGT.NO.1 mM sodium orthovanadate/lO mM 
MpClJO. 1% Triton X-100/5 mM dithiothreitoll2 mM ohenvlmethvlsul- 
foiyl &oride/lO PM pepstatin A/l0 PM leupeptin. Cells iere lysed by 
passage through 25-gauge hypodermic needles, followded by centrifu- 
gation at 13,000 x g for 30 min at 4°C. Unfractionated lysates, or 
column fractions (5-l 0 ~1) were incubated for 15 min at 30°C in a final 
volume of 30 ~1 with either recombmant hsp27 (0.5-l pg) or peptide 
S82 (0.5 mM). Reactions also contained 100 PM [y-“P]ATP (0.5 pCi/ 
nmol), 30 mM p-nitrophenyl-phosphate. 5 PM protein kinase C inhibi- 
tor, 20 PM protein kinase A inhibitor, 10 mM MOPS, pH 7.0 and 10 
mM MgCl,. Reactions containing hsp27 were stopped by adding lo@ 
of a 4 x concentrated SDS-PAGE sample buffer and boiling. The sam- 
ples were electrophoresed on 8-16% polyacrylamide gels [19] which 
were then stained with Coomassie brilliant blue R. dried and exposed 
to Kodak storage phosphor screens. Incorporation of radiolabeled 
phosphate into hsp27 was visualized and quantitated using a phosphor- 
imager (Molecular Dynamics, Sunnyvale, CA). Incorporation of 
[32P]phosphate into S82 peptide or S6 peptide was measured by acidify- 
ing the reaction mixtures with formic acid (25% final concentration) 
and spotting aliquots onto P81 phosphocellulose paper discs. The discs 
were washed with 75 mM phosphoric acid, dried, and Cerenkov 
counted. Preparation of cell lysates containing MAP kinase and assay 
of MAP kinase using T669 peptide substrate have been described in 
detail elsewhere [3]. 
2.3 PeptIde mapping 
KB cells (1 x 10’) were metabollically labelled for 2 h in medium 
supplemented with 0.5 mCi/mI [32P]orthophosphate before addition of 
IL-I or diluent. After a further 15 min, the cells were washed twice with 
cold PBS, lysed in 1 ml of RIPA buffer (20 mM Tris-HCl pH 7.5050 
mM NaCl/l% NP-400% sodium deoxycholate/O.l% SDS/l5 mM p- 
nitrophenylphosphate/lO mM NaF/0.2 mM sodium orthovanadate) 
and clarified by microcentrifugation for 10 min at 4°C. Aliquots of the 
labelled cell lysates were incubated at 4°C for 2 h with 20 pug of anti- 
hsp27 antibody and 10~1 of Pansorbin (Calbiochem). Immunoprecipi- 
tates were washed extensivelv, eluted bv boiling in SDS-PAGE samole 
buffer and resolved by SDS-PAGE. Thk gels w&e subjected to autoia- 
diography to localize Iabelled hsp27 which was excised from the gels. 
eluted, oxidized and digested with TPCK-treated trypsin as described 
[20]. S82 peptide was phosphorylated m the presence of [y-‘*P]ATP and 
a lysate made from IL-l-treated cells as described above. The peptide 
was separeated from unreacted ATP by electrophoresis on a cellulose 
TLC piate in a pH 3.5 buffer (pyridinejacetic a&/water, 10: 100:1890), 
eluted with formic acid and digested with TPCK-trypsin. Radiolabelled 
tryptic fragments of hsp27 and S82 peptide were compared by two- 
dimensional mapping on cellulose TLC plates. The first dimension 
consisted of electrophoresis at either pH 3.5 (1.4 kV, 30 min) or pH 8.9 
(1% ammonium bicarbonate buffer, 1 kV for 25 min). In the second 
dimension, the plates were developed by ascending chromatography in 
n-butanoYacetic acid/pyridine/water (15:3:12:10). The plates were 
analysed using a Phosphorimager. Sequence analysis of “P-labeled S82 
peptide was performed using a modified ABI model 475A liquid-pulsed 
sequencer. Following every cycle of automated NH,-terminal sequence 
analysis 15% of each PTH-amino acid was identified and quantitated; 
the remaining 85% was collected and counted by liquid scintillation 
spectrometry. 
2.4. Partial pur@cation of hsp27 kinase and MAP kinase 
Cell extracts, prepared as described above, were loaded onto a Mono 
Q HR 515 column (Pharmacia) equilibrated with buffer A (25 mM 
HEPES, pH 7.4, 2 mM EDTA, 1 mM DTT, 80 mM /3-glycero- 
phosphate, 0.2 mM PMSF, 2 PM leupeptin, 2 PM pepstatin A. 25 mM 
p-nitrophenyl phosphate and 10% ethylene glycol). All chromato- 
graphic steps were performed at 4°C. After loading, the column was 
washed with five column volumes of buffer A, then eluted with a linear 
salt gradient from O-750 mM NaCl in buffer A. Selected fractions were 
assayed for kinase activity using hsp27, S82 peptide and S6 peptide as 
substrates, the remainder of each fraction was frozen and stored at 
-80°C. Fractions containing the major IL-l-stimulated hsp27 kinase 
activity were thawed and pooled and a portion chromatographed on 
a Superose 12 HR 10130 column (Pharmacia) equilibrated with buffer 
A. Aliquots were removed from selected fractions for kinase assays then 
all fractions were frozen and stored at -80°C. MAP kinase was purified 
from large-scale cultures of IL-l-stimulated KB cells by sequential 
chromatography on DEAE-cellulose, Phenyl-Sepharose and Superose 
12 exactly as described [3]. 
2.5. Dephosphorylation and reactivation of hsp27 kinase 
Hsp27 kinase, partially purified as described above, was divided into 
two portions. One half was concentrated fivefold usmg a Centriprep 10 
concentrator (Amicon), diluted back to the original volume with buffer 
A (containing phosphatase inhibitors) and reconcentrated to one-fifth 
of the original volume. The retentate was than desalted using Bio-Gel 
PdDG spin columns equilibrated in buffer A. The other half of the 
material was subjected to the same procedure except that the buffers 
used for desalting and concentration lacked EGTA and the phosphat- 
ase inhibitors /3 glycerophosphate and p-nitrophenyl phosphate. One 
hundred microliters of the preparation containing phosphatase inhib- 
itors was mixed with 2 ~1 of 2.5 PM okadaic acid, and an equal volume 
of the sample lacking inhibitors was mixed with 2 #I of 10% DMSO 
vehicle. Each mixture was then treated with 0.5 units-of phosphatase-2a 
for 30 min at 30°C. Okadaic acid was then added to the samole lacking 
phosphatase inhibitors (‘inactive hsp27 kinase’), and vehicle to thi 
other sample (‘active hsp27 kinase’). Both preparations were mixed 
with 50 ~1 of a reactivation buffer containing 30 mM MOPS pH 7.5, 
90 mM p-nitrophenyl phosphate, 30 mM p-glycerophosphate, 0.3 mM 
Na,VO,, 0.3 mM Na,MoO,, 30 mM MgC&, 30 mM NaF, 2 mM 
dithiothreitol, 100 PM ATP, 1 mM PMSF, IO PM leupeptin and 10 PM 
pepstatin A. Aliquots (25 ~1) were mixed with 5 ~1 of either partially 
purified MAP kinase (see above, specific activity 0.464 pmol phosphate 
transferred to T669 peptide per minute per PI), purified p44mpk (0.422 
pmollminl~l), recombinant ERK-2 (0.108 pmol/min/@), or buffer con- 
trol. After a further 60 min incubation at 3O”C, 1 pg of hsp27 and 1 
,uCi of [y-‘*P]ATP were added to each tube in 10 ~1 of 20 mM MOPS 
pH 7.5, 10 mM MgCI,, and the reactions were allowed to proceed for 
a further 20 min. The incorporation of [32P]phosphate into hsp27 was 
analysed as described above. 
3. Results 
Extracts prepared from IL-l-treated KB cells were 
incubated with recombinant hsp27 and [Y-~~P]ATP. The 
reaction products were separated by SDS-PAGE and 
visualized by phosphorimaging (Fig. 1). IL-I caused a 
greater than lo-fold increase in the incorporation of 
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Fig. 1. In vitro phosphorylation of recombinant human hsp27 by cyto- 
plasmic extracts from KB cells. Groups of three dishes of KB cells were 
treated with 100 @ml PMA (lanes &6), 20 r&ml IL-1 (lanes 7-9), 50 
ng/ml EGF (lanes 10-12) or phosphate-buffered saline (lanes 1-3 and 
13) for 15 min. Aliquots of cell lysates (10 ~1) were incubated with 
[Y-~‘P]ATP and hsp27 (0.5 pg, lanes 1-12) or diluent (lane 13) in an in 
vitro kinase assay as described in section 2. Phosphorylated proteins 
were separated by SDS-PAGE. Incorporation of [32P]phosphate into 
hsp27 (arrowed) was quantitated using a phosphorimager. A grey-scale 
image is reproduced here, and the increase in hsp27 phosphorylation 
with respect o the resting level (mean fold-induction) is indicated for 
each treatment. 
phosphate into hsp27, consistent with the activation of 
one or more protein kinases. PMA and EGF, which 
cause comparable increases in MAP kinase activity in 
KB cells, also stimulated hsp27 kinase activity to a sim- 
ilar extent. It was important to determine if the kinase(s) 
stimulated by IL-l phosphorylated hsp27 on the same 
sites that have been previously reported for heat shock-, 
mitogen-activated, or endogenously-active kinases from 
various cell lines [13,14]. We accordingly synthesized a 
peptide which corresponded to the amino acids flanking 
these sites. This peptide, S82, was indeed phosphorylated 
to high stoichiometry by extracts from IL-l-treated KB 
cells, at a rate 1.5-3 times that obtained using extracts 
from untreated cells (data not shown). Because the pep- 
tide was also a substrate for the catalytic subunit of 
protein kinase A (data not shown) we routinely included 
a specific inhibitor of this enzyme in our in vitro assays. 
Endogenous hsp27 was immuno-precipitated from rest- 
ing and IL-l-stimulated KB cells metabolically labelled 
with [32P]phosphate. This material, comprising a mixture 
of all phosphorylated isoforms, together with 
phosphorylated peptide S82, was digested with trypsin 
and 2D-phosphopeptide maps were prepared (Fig. 2). 
IL-l treatment of intact cells caused an increase in the 
intensity of a major phosphopeptide (peptide 1 in the 
figure) and the appearence of two new phosphopeptides 
(4 and 5) when the first-dimension electrophoresis was 
carried out at pH 8.9. All of these peptides, and a faint 
additional peptide (number 2) were detectable in digests 
of phosphorylated peptide S82. If electrophoresis was 
performed at pH 3.5, two major and one minor peptide 
were detected in extracts from IL-l-stimulated cells, 
these were superimposible with peptides derived from 
peptide S82 (not shown). 
We next compared the time courses for IL-l-stimu- 
lated phosphorylation of hsp27, peptide S82, and a pep- 
tide based upon the RSK phosphorylation site in ribo- 
somal protein S6, with the time course of MAP kinase 
activation (Fig.3). Although the basal and maximally 
stimulated levels of the various activities differed consid- 
erably, all displayed similar transient kinetics, with the 
peak of hsp27 kinase activity being just slightly later than 
the peak of MAP kinase activity. Phosphorylation of S82 
and S6 peptides was particularly well correlated. 
In order to characterise the IL-l-stimulated hsp27 ki- 
nase further, we fractionated extracts from resting and 
IL-l-stimulated KB cells by ion-exchange chromatogra- 
phy. A major peak (peak II) and minor peak (peak III) 
of hsp27 kinase activity were found in untreated cell 
extracts eluting at 230 mM and 320 mM NaCl, respec- 
tively (Fig. 4a). Peak III was unchanged in IL-l-stimu- 
lated cells and was not characterized further. Extracts 
from IL-l-stimulated cells contained a new peak (peak 
I) which eluted at 180 mM NaCl, but which also con- 
tained a shoulder coinciding with the peak II present in 
control cells. Whether peak I represents a kinase not 
active in resting cells or arises as a result of an activating 
modification of peak II hsp27 kinase is not clear at this 
time. Column fractions were also assayed for RSK activ- 
ity using the S6 peptide substrate. More variable results 
were obtained, but usually at least four poorly-resolved 
.IL- 1 
c 
3* . “b 
tIL- 1 
In vivo labeling 
I 
1 SE2 oeotide + extract 
Fig. 2. Two-dimensional phosphopeptide mapping of hsp27. KB cells 
were metabolically labeled with [‘2P]orthophosphate then treated with 
IL-l or vehicle for 15 min. Hsp27 was immunoprecipitated from lysates 
of the cells and purified by SDS-PAGE, and digested with TLCK- 
treated trypsin. Peptide S82 (36 nmol) was phosphorylated in vitro 
using hsp27 kinase from IL-l-treated KB cells. Radiolabeled peptide 
was purified by thin-layer electrophoresis and also digested with 
TLCK-trypsin under identical conditions. Samples of the hsp27 pep- 
tides from resting cells (70 Cerenkov counts/min, top left), IL-l-treated 
cells (100 cpm, bottom left), and S82 peptide (170 cpm, bottom right) 
were spotted onto TLC plates (0 = origin) and subjected to two dimen- 
tional mapping as described in section 2. 
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Fig. 3. Kinetics of activation of protein kinase activities by IL-l. KB 
cells were stimulated for various times with IL-l (20 @ml) or were left 
unstimulated; lysates were prepared and assayed for their ability to 
phosphorylate hsp27 (600 nM in the kinase assay) or peptides T669 (1 
mM, MAP kinase activity), S82 (0.5 mM) and S6 (0.5 mM). The max- 
imum fold-increase of each kinase activity is indicated in parentheses. 
peaks of activity were observed from both stimulated 
and unstimulated extracts (Fig. 4b). There was a superfi- 
cial similarity in the activity profiles of peptide S6 kinase 
and the hsp27 kinase in the region of peaks I and II, 
though the difference between stimulated and unstimu- 
lated levels was not as great as with hsp27 kinase. The 
other kinases detected using S6 peptide as substrate were 
apparently incapable of phosphorylating hsp27. Mono 
Q fractions were also assayed for kinase activity using 
peptide S82 as substrate and the activity profile corre- 
lated precisely with that obtained using S6 peptide (data 
not shown). Peak I hsp27 kinase was further fractionated 
by size exclusion chromatography on Superose 12 (Fig. 
4~). Three partially resolved peaks of activity were found 
that were capable of phosphorylating peptide S82; 
eluting at positions expected for proteins of molecular 
mass around 150 kDa, a broad shoulder at 45-60 kDa, 
and at 25-30 kDa, respectively (data not shown). How- 
ever, only a single peak of hsp27 kinase was detected, at 
a position corresponding to the 45-60 kDa peak of S82 
kinase activity. More importantly, S6 kinase activity was 
clearly resolved from hsp27 kinase. and comprised a 
major peak eluting just within the included volume of the 
column, and a smaller peak which eluted later than 
hsp27 kinase (Fig. 4~). Some of the hsp27 kinase peak 
was used to phosphorylate peptide S82 in the presence 
of [Y-~~P]ATP. During radiosequence analysis of the 
phosphorylated peptide. radioactivity was recovered 
after six and ten degradative cycles indicating that the 
phosphorylated residues coresponded to Ser78 and Sers2. 
respectively (data not shown). 
Some of the protein serine/threonine kinases thought 
to be involved in the response of cells to mitogens are 
known to be regulated by phosphorylation catalysed by 
upstream regulatory kinases [4,15]. We attemped to de- 
termine if the same was true for hsp27 kinase. A sample 
of partially-purified hsp27 kinase was subjected to a two- 
stage procedure designed to dephosphorylate potentially 
regulatory phosphoaminoacids in hsp27 kinase. The first 
step involved the removal of phosphatase inhibitors. The 
second step consisted of treating this material with puri- 
fied protein phosphatase-2a (PP-2a), which selectively 
dephosphorylates phosphoserine and phosphothreonine 
residues. Fig. 5 shows that hsp27 kinase treated with 
PP-2a and then with okadaic acid (a selective and ex- 
tremely potent inhibitor of this enzyme) contained only 
18% of the activity of hsp27 kinase treated with okadaic 
acid prior to PP-2a. (compare the left-hand lanes in pan- 
els 2 and 3, respectively). In initial experiments (not 
-0 10 20 30 40 50 60 
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158k~a 44kDa 17 kDa 
- 400 
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Fig. 4. Chromatographic characterization of IL-1-stimulated hsp27 
kinase. (a) Lysates prepared from four confluent 175 cm’ flasks of 
IL-l-stimulated KB cells (~7) or resting cells (0) were applied to a Mono 
Q column. The column was developed as described in section 2. Ali- 
quots of selected fractions were assayed for their ability to phospho- 
rylate hsp27. In (b) the same fractions were assayed for peptide S6 
kinase activity. (c) IL-l-stimulated fractions 17-19 from the Mono Q 
column were pooled, concentrated and chromatographed on a Super- 
ose 12 column as described in section 2. Selected fractions were assayed 
for kinase activity using either hsp27 (a) or peptide S6 (0) as substrate. 
Molecular mass standards used to calibrate the column were bovine 
y-globulin (158 kDa), chicken ovalbumin (44 kDa), and equine myo- 
globin (17 kDa). 
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Fig. 5. Inactivation of hsp27 kinase by de-phosphorylation and re-activation by MAP kinase. Partially-purified hsp27 kinasewas de-phosphorylated 
by treatment with PP-2a followed by okadaic acid (panel 2) or maintained in a phosphorylated active state by addition of okadaic acid prior to PP-2a 
(panel 3). Aliquots of each sample were incubated in the presence of ATP, magnesium, and either a buffer control (basal), partially-purified MAP 
kinase (fraction 28), p44mpk, or recombinant ERK-2, as indicated. Subsequently, [Y-‘~P]ATP and hsp27 were added. The MAP kinases were also 
incubated with hsp27 in the absence of hsp27 kinase (panel 1). Incorporation of labeled phosphate into hsp27 (arrowed) was determined as described 
in section 2. 
shown) cell lysates were depleted of MAP kinase by pas- 
sage over DEAE Sephacel. Hsp27 kinase in these crude 
preparations was inactivated by de-phosphorylation and 
could be fully re-activated when mixed with a small 
amount of unfractionated cell extract in the presence of 
MgCl, and ATP, the re-activating activity was retained 
by DEAE-Sephacel and phenyl sepharose columns and 
co-chromatographed with MAP kinase on an analytical 
size exclusion chromatography column. We therefore 
tested various MAP kinase preparations for their ability 
to re-activate the partially purified de-phosphorylated 
hsp27 kinase (Fig. 5, panel 2). The peak fraction of IL- 
1 -stimulated MAP-kinase from Superose 12 (fraction 28 
in Fig. 5) re-activated hsp27 kinase to about 50% of the 
control activity, sea star p44mpk, with the same specific 
activity against T669 peptide also re-activated hsp27 ki- 
nase to a similar extent. Recombinant ERK-2, activated 
in vitro with MAP kinase kinase caused a lesser activa- 
tion, but this preparation also contained less T669-phos- 
phorylating activity. None of the MAP kinase prepara- 
tions enhanced the activity of ‘active’ hsp27 kinase (Fig. 
5, panel 3). In the absence of added hsp27 kinase, neither 
p44mpk nor ERK-2 were capable of detectably phospho- 
rylating hsp27. A very low level of endogenous hsp27 
phosphorylation was detected in partially purified IL-l- 
stimulated MAP kinase attributable to the small amount 
of hsp27 kinase which binds to DEAE-cellulose and co- 
elutes with MAP kinase upon phenyl Sepharose chroma- 
tography (GDV and TAB, unpublished); this activity 
was too small to acount for the observed re-activation, 
however. 
4. Discussion 
Here we provide an initial characterization of the IL- 
l-stimulated protein serine kinase that phosphorylates 
hsp27. An earlier study by Guesdon and Saklatvala [21] 
demonstrated that cytosolic extracts of IL-l-stimulated 
MRC-5 fibroblasts phosphorylated hsp27 at a greater 
rate than unstimulated cells to produce the same set of 
phosphorylated hsp27 isoforms as were seen in intact 
cells metabolically labeled with [32P]phosphate. Landry 
and co-workers [13] reported that heat shock and mito- 
gens (serum, thrombin, and fibroblast growth factor) 
co-induced kinases that were able to phosphorylate 
hsp27 and ribosomal protein S6 in vitro. Similarly, the 
murine homolog of hsp27, hsp25, was phosphorylated in 
vitro by an endogenous kinase from Ehrlich ascites cells 
[14]. No biochemical characterization of the activated 
kinase(s) was reported in these studies. In our study we 
found a single major peak of IL-1-stimulatable hsp27 
kinase activity (peak I) which was also capable of phos- 
phorylating a peptide substrate. However, there are 
clearly a number of other kinases present in both IL-l- 
treated and resting cells which will phosphorylate the 
36 TA. Bird et al. IFEBS Letters 338 (1994) 31-36 
peptide substrates but not hsp27. Upon size exclusion 
chromatography, peak I hsp27 kinase eluted as a 45-60 
kDa protein, distinguishing it from previously described 
S6 kinases of 70 kDa and 90 kDa [223. Notably, only one 
of three S82 peptide kinases resolved by size exclusion 
chromatography phosphorylated recombinant hsp27. 
Taken together, the chromatographic data suggest hat 
the phosphorylation site present in the folded hsp27 pol- 
ypeptide may be accessible to hsp27 kinase but not to 
these other kinases. 
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